The building was completed in December 2020
The business will be part of the pharma services business within the laboratory products and services segment
The companies will look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules
Udo Losehand, Head of Global Technical Developers, Roquette, explains everything you need to know about single-use ...
The centre is being used for the worldwide manufacture and distribution of the COVID-19 vaccine by AstraZeneca
This funding will speed up the platform development and scale-up, with the objective to allow routine clinical grade ...
Advances in the single-cell genomic analysis of cells and tissues, including the required computational methods, have ...
The facility at the site in Cork is currently in development and will be validated to ISO 9001 Quality Management ...
The two companies have partnered to establish a biologics and sterile drug manufacturing facility in China
Cell and gene therapy treatments offer the hope of a cure for diseases that would otherwise result in a lifetime of ...
Immunotherapies such as ADCs deliver a more targeted treatment against cancer that improves the quality of life for the ...
Dr Andrea Traube, Director of Market Development, Pharma, at OPTIMA pharma, and Dena Flamm, Business Development ...
Boulting has been chosen to fit out a new facility for the not for profit organisation established to provide the UK's ...
Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease ...